.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Cantor Fitzgerald
Queensland Health
Accenture
Moodys
McKinsey
UBS
Farmers Insurance
Colorcon
Baxter

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074983

« Back to Dashboard

NDA 074983 describes ETOPOSIDE, which is a drug marketed by Mylan, Accord Hlthcare, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Pharmachemie Bv, Pierre Fabre, Teva Parenteral, Teva Pharms Usa, Watson Labs, Watson Labs Inc, and West-ward Pharms Int, and is included in fourteen NDAs. It is available from six suppliers. Additional details are available on the ETOPOSIDE profile page.

The generic ingredient in ETOPOSIDE is etoposide. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the etoposide profile page.

Summary for 074983

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 074983

Mechanism of ActionTopoisomerase Inhibitors

Medical Subject Heading (MeSH) Categories for 074983

Suppliers and Packaging for NDA: 074983

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ETOPOSIDE etoposide INJECTABLE;INJECTION 074983 ANDA Fresenius Kabi USA, LLC 63323-104 63323-104-25 1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-25) > 25 mL in 1 VIAL, MULTI-DOSE
ETOPOSIDE etoposide INJECTABLE;INJECTION 074983 ANDA Fresenius Kabi USA, LLC 63323-104 63323-104-50 1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-50) > 50 mL in 1 VIAL, MULTI-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/ML
Approval Date:Sep 30, 1998TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
UBS
Johnson and Johnson
Fuji
Chubb
Farmers Insurance
Cantor Fitzgerald
Teva
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot